A Practical Guide for the Current Use of Biologic Therapies in Sports Medicine
- PMID: 31038990
- DOI: 10.1177/0363546519836090
A Practical Guide for the Current Use of Biologic Therapies in Sports Medicine
Abstract
Over the past decade, there has been an increased interest in the use of biologic therapies in sports medicine. Although these technologies are in relatively early stages of development, there have been substantial increases in marketing, patient demand, and clinical utilization of biologics, including platelet-rich plasma, bone marrow aspirate concentrate, and other cell-derived therapies. Direct-to-consumer marketing of biologics has also proliferated but is largely unregulated, and clinicians must accurately convey the safety and efficacy profiles of these therapies to patients. Because most insurance companies consider biologic treatments to be experimental or investigational for orthopaedic applications given the lack of high-quality evidence to support their efficacy, patients receiving these treatments often make substantial out-of-pocket payments. With a range of treatment costs among centers offering biologics, there is a need for appropriate and sustainable pricing and reimbursement models. Clinicians utilizing biologics must also have a thorough understanding of the recently clarified Food and Drug Administration guidelines that regulate the clinical use of cell and tissue products. There is a lack of consensus on the optimal preparation, source, delivery method, and dosing of biologic therapies, which has been exacerbated by a lack of sufficient experimental detail in most published studies. Future research must better identify the biologic target of treatment, adhere to better standards of reporting, and better integrate researchers, industry, and regulatory bodies to optimize applications.
Keywords: BMAC; PRP; biologics; bone marrow aspirate; platelet-rich plasma; stem cells.
Similar articles
-
Editorial Commentary: Risks of Biologic Therapies in Sports Medicine: Landmines on the Road to the Holy Grail.Arthroscopy. 2021 Aug;37(8):2606-2607. doi: 10.1016/j.arthro.2021.06.003. Arthroscopy. 2021. PMID: 34353564
-
Responsible, Safe, and Effective Use of Biologics in the Management of Low Back Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.Pain Physician. 2019 Jan;22(1S):S1-S74. Pain Physician. 2019. PMID: 30717500
-
Incorporating Ortho-Biologics into Your Clinical Practice.Clin Sports Med. 2019 Jan;38(1):163-168. doi: 10.1016/j.csm.2018.08.008. Clin Sports Med. 2019. PMID: 30466720 Review.
-
Biological treatment of the knee with platelet-rich plasma or bone marrow aspirate concentrates.Acta Orthop. 2017 Dec;88(6):670-674. doi: 10.1080/17453674.2017.1368899. Epub 2017 Aug 23. Acta Orthop. 2017. PMID: 28831830 Free PMC article. Review.
-
Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): Platelet-Rich Plasma and Mesenchymal Stem Cells.J Bone Joint Surg Am. 2017 May 17;99(10):809-819. doi: 10.2106/JBJS.16.00793. J Bone Joint Surg Am. 2017. PMID: 28509821
Cited by
-
Treatment of Tendon Injuries in the Servicemember Population across the Spectrum of Pathology: From Exosomes to Bioinductive Scaffolds.Bioengineering (Basel). 2024 Feb 5;11(2):158. doi: 10.3390/bioengineering11020158. Bioengineering (Basel). 2024. PMID: 38391644 Free PMC article. Review.
-
Orthobiologics as an adjunct in treatment of femoroacetabular impingement syndrome: cell-based therapies facilitate improved postoperative outcomes in the setting of acetabular chondral lesions-a systematic review.Knee Surg Sports Traumatol Arthrosc. 2023 Dec;31(12):6020-6038. doi: 10.1007/s00167-023-07624-4. Epub 2023 Oct 31. Knee Surg Sports Traumatol Arthrosc. 2023. PMID: 37906291 Review.
-
Intra-articular delivery of micronized dehydrated human amnion/chorion membrane reduces degenerative changes after onset of post-traumatic osteoarthritis.Front Bioeng Biotechnol. 2023 Sep 6;11:1224141. doi: 10.3389/fbioe.2023.1224141. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37744252 Free PMC article.
-
Substantial Variability in Platelet-Rich Plasma Composition Is Based on Patient Age and Baseline Platelet Count.Arthrosc Sports Med Rehabil. 2023 May 20;5(3):e853-e858. doi: 10.1016/j.asmr.2023.03.017. eCollection 2023 Jun. Arthrosc Sports Med Rehabil. 2023. PMID: 37388884 Free PMC article.
-
Process Optimization and Efficacy Assessment of Standardized PRP for Tendinopathies in Sports Medicine: Retrospective Study of Clinical Files and GMP Manufacturing Records in a Swiss University Hospital.Bioengineering (Basel). 2023 Mar 25;10(4):409. doi: 10.3390/bioengineering10040409. Bioengineering (Basel). 2023. PMID: 37106596 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous